Trial Profile
Single dose study of GT863 in Japanese male healthy adult subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs GT 863 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 15 Jun 2016 Status changed from active, no longer recruiting to completed.
- 20 May 2016 New trial record